- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/04 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 277/04
Total number of patents in this class: 110
10-year publication summary
|
2
|
3
|
12
|
5
|
3
|
4
|
5
|
5
|
6
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Medshine Discovery Inc. | 587 |
4 |
| Cassava Science, Inc. | 14 |
4 |
| FUJIFILM Corporation | 30514 |
3 |
| Oncternal Therapeutics, Inc. | 35 |
3 |
| Gliapharm SA | 19 |
3 |
| Corteva Agriscience LLC | 2648 |
3 |
| The Regents of the University of California | 20745 |
2 |
| Allergan, Inc. | 2167 |
2 |
| Massachusetts Institute of Technology | 10251 |
2 |
| Abbvie Inc. | 1836 |
2 |
| Cancer Research Technology, LLC | 4 |
2 |
| Chevron Phillips Chemical Company LP | 1861 |
2 |
| Immunomet Therapeutics Inc. | 31 |
2 |
| Nagoya Industrial Science Research Institute | 18 |
2 |
| Neuropro Therapeutics, Inc. | 22 |
2 |
| Nippon Zoki Pharmaceutical Co., Ltd. | 130 |
2 |
| University of Tennessee Research Foundation | 763 |
2 |
| Hangzhou Solipharma Co., Ltd. | 42 |
2 |
| Merck Sharp & Dohme LLC | 3734 |
2 |
| Filana Therapeutics, Inc. | 2 |
2 |
| Other owners | 62 |